Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Contrast Nephropathy During Diagnostic Coronary Angiogram or PCI With Hydratation Based on LEVDP

NCT00584350 is registered in ClinicalTrials.gov with Université de Sherbrooke as lead sponsor.

NCT NCT00584350
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00584350 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Contrast Nephropathy During Diagnostic Coronary Angiogram or PCI With Hydratation Based on LEVDP
Lead sponsor
Université de Sherbrooke
Phase
Phase 4
Overall status
Unknown status
Start date
November 30, 2007
Completion date
December 31, 2015
Enrollment
330 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary heart disease, radiographic contrast agent nephropathy, renal failure